Ipilimumab/Nivolumab and Geriatric Care: Valuing Patient Priorities ByAntonio Ocejo, MDMarch 5th 2026Antonio Ocejo, MD, discusses supportive care implications from new data comparing ipilimumab/nivolumab in older vs younger age groups with mccRCC.